Heterozygous LPL deficiency is more common as it is estimated to be present in 3–7% of the general population [31–34], and is known to be associated with a greater risk of dyslipidemia, metabolic syndrome and atherosclerosis [35, 36]. Here, LPL is linked to metabolic syndrome.